EGFR and pancreatic neoplasm: Gao et al. found that nimotuzumab combined with gemcitabine-based chemoradiation promotes the enhancement of the cell cycle arrest, growth suppression, and apoptosis of EGFR-overexpressed pancreatic cancer cell lines PANC-1 [15].